Clinical and metabolic effects associated with weight changes and obeticholic acid in non‐alcoholic steatohepatitis

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|47|5|645-656

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.47, Iss.5, 2018-03, pp. : 645-656

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Beneficial effects of mineralocorticoid receptor blockade in experimental non‐alcoholic steatohepatitis

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 9, 2015-09 ,pp. : 2129-2138

John Wiley & Sons Inc

Access to resources Recommend Favorite

Liraglutide for NASH/NAFLD

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 3, 2015-03 ,pp. : 269-278

John Wiley & Sons Inc

Access to resources Recommend Favorite

Response to Importance of confounding factors in assessing fatty acid compositions in patients with non‐alcoholic steatohepatitis

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 6, 2015-06 ,pp. : 1773-1773

John Wiley & Sons Inc

Access to resources Recommend Favorite

Importance of confounding factors in assessing fatty acid compositions in patients with non‐alcoholic steatohepatitis

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 6, 2015-06 ,pp. : 1772-1772

John Wiley & Sons Inc

Access to resources Recommend Favorite

The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids

By  

HEPATOLOGY, Vol. 67, Iss. 2, 2018-02 ,pp. : 534-548

John Wiley & Sons Inc

Access to resources Recommend Favorite